VIENNA—Understanding the emerging genomic landscape of breast cancer needed international research including large molecular screening projects—according to Peter Campbell MD PhD, head of Cancer Genet
VIENNA—Understanding the emerging genomic landscape of breast cancer needed international research including large molecular screening projects—according to Peter Campbell MD PhD, head of Cancer Genetics and Genomics at the Sanger Institute in Cambridge and joint head of the Cancer Genome Project—speaking at the St Gallen Breast Cancer Conference. He gave Oncology Times reporter Sarah Maxwell his insights into how breast cancer genomics can be applied to the clinic.